中华临床免疫和变态反应杂志2017，Vol.11Issue(2)：184-191,8.DOI:10.3969/j.issn.1673-8705.2017.02.015
妊娠期哮喘用药的安全性
Safety of Pharmacotherapy Options for Asthmatic Patients during Pregnancy
李丽莎 1尹佳1
作者信息
- 1. 中国医学科学院 北京协和医学院 北京协和医院变态(过敏)反应科,北京 100730
- 折叠
摘要
Abstract
Asthma is considered to be one of the most common chronic diseases among pregnant women, and uncontrolled asthma may adversely affect both maternal quality of life and perinatal outcomes.Therefore, optimal management of asthma during pregnancy is important for both mother and fetus.The safety of medications commonly used in the treatment of asthma during pregnancy was reviewed this article.It was shown that no increased perinatal risks, including preterm birth, low birth weight, and congenital malformations, associated with gestational use of inhaled corticosteroids by results of many studies.Although there have been controversies over the issues whether systemic corticosteroids or bronchodilators could cause adverse pregnancy outcomes, the possibility of confounding by severity of maternal asthma could not be ruled out.Therefore appropriate treatment still should be given to the pregnant asthmatic patients without delay when necessary.关键词
哮喘/妊娠/糖皮质激素类/支气管扩张药/白三烯拮抗剂Key words
asthma/pregnancy/corticosteroids/bronchodilator agent/leukotriene antagonist分类
医药卫生引用本文复制引用
李丽莎,尹佳..妊娠期哮喘用药的安全性[J].中华临床免疫和变态反应杂志,2017,11(2):184-191,8.
